iCLAS™ for Persistent Atrial Fibrillation

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2024

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

Adagio AF Cryoablation System (iCLAS™)

Endovascular ablation of the left and right atrium

Trial Locations (21)

10305

Staten Island University Hospital - Northwell Health, Staten Island

21205

Johns Hopkins University, Baltimore

30342

Emory St. Joseph's Hospital, Atlanta

32224

Mayo Clinic, Jacksonville

35243

Grandview Medical Center, Birmingham

43214

Ohio Health Research Institute, Columbus

60208

Northwestern University, Evanston

62701

Prairie Heart Research Institute, Springfield

72401

St. Bernards Medical Center, Jonesboro

77030

Baylor St. Luke's Medical Center, Houston

80120

South Denver Cardiology Associates, Denver

85006

Banner Health, Phoenix

87102

New Mexico Heart Institute, Albuquerque

92093

University of California San Diego, San Diego

02114

Massachusetts General Hospital, Boston

07450

The Valley Hospital, Ridgewood

Unknown

Onze Lieve Vrouwziekenhuis, Aalst

ZNA Middelheim, Antwerp

St. Antonius Ziekenhuis Nieuwegein, Nieuwegein

L3Y 2P9

Southlake Regional Medical Centre, Newmarket

3015 GD

Erasmus University Medical Center, Rotterdam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Adagio Medical

INDUSTRY

NCT04061603 - iCLAS™ for Persistent Atrial Fibrillation | Biotech Hunter | Biotech Hunter